Compare NBTX & DRVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NBTX | DRVN |
|---|---|---|
| Founded | 2003 | 1972 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Automotive Aftermarket |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 2.0B |
| IPO Year | 2018 | 2020 |
| Metric | NBTX | DRVN |
|---|---|---|
| Price | $37.81 | $14.62 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 8 |
| Target Price | ★ $36.00 | $18.33 |
| AVG Volume (30 Days) | 67.4K | ★ 1.0M |
| Earning Date | 03-31-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 146.70 |
| EPS | N/A | ★ 0.33 |
| Revenue | N/A | ★ $1,862,438,000.00 |
| Revenue This Year | $58.17 | N/A |
| Revenue Next Year | N/A | $1.53 |
| P/E Ratio | ★ N/A | $42.76 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.79 | $9.80 |
| 52 Week High | $57.14 | $19.74 |
| Indicator | NBTX | DRVN |
|---|---|---|
| Relative Strength Index (RSI) | 51.60 | 62.59 |
| Support Level | $30.15 | $14.28 |
| Resistance Level | $38.29 | $15.91 |
| Average True Range (ATR) | 2.46 | 0.54 |
| MACD | 0.45 | 0.15 |
| Stochastic Oscillator | 67.69 | 91.49 |
Nanobiotix SA is a late-stage clinical biotechnology company focused on re-inventing medicine by building new therapies atom by atom, developing widely applicable, first-in-class, physics-based nanotherapeutics to transform treatment outcomes and expand life for millions of patients. The objective of this physics-based approach is to allow nanoparticles to be combined with other drugs or therapeutic modalities and to integrate seamlessly into clinical practice without adding burden for the patient, healthcare provider, or healthcare system. It has three platforms Nanoradioenhancer platform: Nanoprimer platform: and Neurological disease platform. It has one segment, which is the research and development of product candidates that use proprietary nanotechnology to transform cancer treatment.
Driven Brands Holdings Inc is an automotive services company in North America. Its platform provides high-quality services to an extensive range of retail and commercial customers. The company provides an extensive range of core consumer and commercial automotive needs, including paint, collision, glass, and repair services, as well as a variety of high-frequency services, such as oil changes and car washes. The company segments include: Maintenance, Car Wash, Paint, Collision & Glass, and Platform Services. It derives maximum revenue from Maintenance Segment. Geographically, the company operates into United States, Canada and Rest of the World.